Affinity Group Limited

Nexus Oncology is a niche CRO specialising in oncology drug development services for the biopharmaceutical industry.

Founded in 1999, Nexus Oncology has an excellent reputation for client service and has grown through recommendations from existing sponsors and study sites, as well as repeat business from satisfied clients. Nexus Oncology is a CRO with a reputation for excellence.

Nexus offer a full range of drug development services and manage all major European projects from their UK headquarters in a modern, purpose-built science park near Edinburgh. Nexus also have offices in France and Switzerland and employ a number of field-based personnel throughout Europe.

Nexus Oncology offers a flexible range of services that can be adapted to suit the individual projects of their sponsors and clients and with a well-established track record of working with many novel therapeutic approaches, the clinical research team at Nexus has conducted in excess of 200 clinical studies in oncology.